ERBB2 and neoplasm: Furthermore, Mazzarella et al. reported that BMI ≥ 30 kg/m2 was correlated with shorter overall survival and increased incidence of distant metastases in HER2 + ER− breast cancer whereas the outcome in HER2 + ER + tumours did not significantly differ between the different BMI groups30.